Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Imaging of the Hypoxic Tumor Microenvironment to Predict Response to Yttirum-90 Selective Internal Radiation Therapy in Hepatocellular Carcinoma- Pilot Study

NCT05250895 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT05250895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05250895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Imaging of the Hypoxic Tumor Microenvironment to Predict Response to Yttirum-90 Selective Internal Radiation Therapy in Hepatocellular Carcinoma- Pilot Study
Lead sponsor
Emory University
Phase
Phase 1
Overall status
Completed
Start date
April 28, 2022
Completion date
February 26, 2025
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bclc stage a hepatocellular carcinoma, bclc stage b hepatocellular carcinoma, bclc stage c hepatocellular carcinoma, hepatocellular carcinoma